Non-secretory multiple myeloma: Diagnosis and management

被引:12
作者
Charlinski, Grzegorz [1 ,2 ]
Jurczyszyn, Artur [3 ]
机构
[1] Univ Warmia & Mazury, Dept Internal Med, Olsztyn, Poland
[2] Minist Interior & Adm Hosp, Dept Hematol, Warmian Masurian Canc Ctr, Olsztyn, Poland
[3] Jagiellonian Univ Coll Med, Fac Med, Plasma Cell Dyscrasias Ctr, Dept Hematol, Krakow, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2022年 / 31卷 / 01期
关键词
diagnosis; management; non-secretory multiple myeloma; IMAGING TECHNIQUES; TRANSPLANTATION; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; CRITERIA; OUTCOMES; DISEASE; CHAIN; AGE;
D O I
10.17219/acem/141455
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. One criterion for the diagnosis of MM is serum and/or urine monoclonal protein produced by clonal plasmocytes. However, about 1-2% of MM cases do not have monoclonal protein. If other diagnostic criteria are present, the possibility of a di-agnosis of non-secretory MM should be considered. As the different types of non-secretory MM depend on the underlying cause, the current definition is considered insufficient. Currently, both the diagnosis and treatment of non-secretory MM are the same as those of secretory MM. Due to the rarity of non-secretory MM, most findings are from retrospective studies on small groups of patients and case reports. The method of monitoring the effectiveness of MM treatment remains a problem, as it is usually based on the assessment of the percentage of clonal plasma cells in the bone marrow and imaging studies.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
[31]   Non Secretory Multiple Myeloma With Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma [J].
Low, Soo Fin ;
Tap, Nor Hanani Mohd ;
Kew, Thean Yean ;
Ngiu, Chai Soon ;
Sridharan, Radhika .
IRANIAN JOURNAL OF RADIOLOGY, 2015, 12 (03)
[32]   Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study [J].
Qin, Xiao-Qi ;
An, Gang ;
Li, Zeng-Jun ;
Liu, Lan-Ting ;
Xu, Yan ;
Yang, Lin-Hua ;
Ma, Yan-Ping ;
Deng, Shu-Hui ;
Sui, Wei-Wei ;
Qin, Yu ;
Feng, Xiao-Yan ;
Zang, Mei-Rong ;
Yang, Wen-Juan ;
Zhang, Yan-Ru ;
Yi, Shu-Hua ;
Wang, Ting-Yu ;
Lv, Rui ;
Zou, De-Hui ;
Zhao, Yao-Zhong ;
Qiu, Lu-Gui .
BLOOD ADVANCES, 2019, 3 (05) :751-760
[33]   Delayed diagnosis of multiple myeloma in a young patient: a call for vigilance in diagnosis [J].
Patel, Jigar ;
Degann, Seta ;
Ahmad, Mohammad ;
Lesky, Linda .
BMJ CASE REPORTS, 2025, 18 (01)
[34]   Multiple myeloma Updated approach to management in 2018 [J].
Tomlinson, Ross .
AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2018, 47 (08) :526-529
[35]   New and emerging pharmacotherapies for the management of multiple myeloma [J].
Moore, Donald C. ;
Oxencis, Carolyn J. ;
Shank, Brandon R. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (14) :1137-1145
[36]   Updates in the management of relapsed/refractory multiple myeloma [J].
Hanna, Kirollos S. ;
Larson, Samantha ;
Nguyen, Jenny ;
Tu, Sarah ;
Boudreau, Jenna ;
Rose, Sarah .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (06) :1477-1490
[37]   Diagnosis and Management of Monoclonal Gammopathy and Smoldering Multiple Myeloma [J].
Schmidt, Timothy M. ;
Callander, Natalie S. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (12) :1720-U74
[38]   Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management [J].
Kundu, Sumana ;
Jha, Surajkumar B. ;
Rivera, Ana P. ;
Monar, Gabriela V. Flores ;
Islam, Hamza ;
Puttagunta, Sri Madhurima ;
Islam, Rabia ;
Sange, Ibrahim .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
[39]   Carfilzomib in multiple myeloma: unraveling cardiac toxicities - from mechanisms to diagnosis and management [J].
Gao, Yi ;
Zhou, Di ;
Bai, Xue ;
Wang, Yunjie ;
Wang, Chenchen ;
Bi, Lintao .
FRONTIERS IN PHARMACOLOGY, 2025, 16
[40]   Management of induction failures in newly diagnosed transplant-eligible multiple myeloma [J].
Gertz, Morie A. .
LEUKEMIA & LYMPHOMA, 2020, 61 (01) :1-3